SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-324541
Filing Date
2020-12-22
Accepted
2020-12-22 16:15:01
Documents
14
Period of Report
2020-12-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d102870d8k.htm   iXBRL 8-K 27159
2 EX-99.1 d102870dex991.htm EX-99.1 4242
6 GRAPHIC g102870g1222231511761.jpg GRAPHIC 3206
  Complete submission text file 0001193125-20-324541.txt   164402

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20201221.xsd EX-101.SCH 3077
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20201221_lab.xml EX-101.LAB 18841
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20201221_pre.xml EX-101.PRE 11844
7 EXTRACTED XBRL INSTANCE DOCUMENT d102870d8k_htm.xml XML 3568
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 201408135
SIC: 2835 In Vitro & In Vivo Diagnostic Substances